Zobrazeno 1 - 9
of 9
pro vyhledávání: '"D. di Carlo"'
Autor:
Falasca F; Department of Molecular Medicine, 'Sapienza' University of Rome, Italy., De Vito C; Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Italy., Mazzuti L; Department of Molecular Medicine, 'Sapienza' University of Rome, Italy., di Carlo D; Department of Molecular Medicine, 'Sapienza' University of Rome, Italy., Celani L; Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Italy., Fimiani C; Department of Infectious Diseases, Umberto I University Hospital, Rome, Italy., dʼEttorre G; Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Italy., Mezzaroma I; Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Italy., Antonelli G; Department of Molecular Medicine, 'Sapienza' University of Rome, Italy., Turriziani O; Department of Molecular Medicine, 'Sapienza' University of Rome, Italy.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2019 Apr 01; Vol. 80 (4), pp. 423-428.
Autor:
Armenia D; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.; Saint Camillus International University of Health Sciences, Rome, Italy., Di Carlo D; Pediatric Clinical Research Center 'Romeo and Erica Invernizzi', University of Milan, Milan, Italy., Cozzi-Lepri A; Institute for Global Health London, University College London, London, UK., Calcagno A; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy., Borghi V; Clinic of Infectious Diseases, University Hospital, University of Modena and Reggio Emilia, Modena, Italy., Gori C; Virology Unit, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Bertoli A; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Gennari W; Microbiology and Virology Unit, University Hospital Polyclinic, Modena, Italy., Bellagamba R; Clinical Division of HIV/AIDS, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Castagna A; Infectious Diseases Department, IRCCS San Raffaele Scientific Institute & Vita-Salute University, Milan, Italy., Latini A; Unit of Dermatology and Sexually Transmitted Diseases, San Gallicano Dermatological Institute IRCCS, Rome, Italy., Pinnetti C; Clinical Division of HIV/AIDS, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Cicalini S; Clinical Division of HIV/AIDS, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Saracino A; Division of Infectious Diseases, University of Bari, Policlinic Hospital, Bari, Italy., Lapadula G; Division of Infectious Diseases, 'San Gerardo' Hospital, Monza, Italy., Rusconi S; Infectious Diseases Unit, DIBIC Luigi Sacco, University of Milan, Milan, Italy., Castelli F; University Department of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Brescia, Italy., Di Giambenedetto S; Infectious Diseases Unit, Catholic University of Sacred Heart, Rome, Italy., Andreoni M; Clinical Infectious Diseases, University Hospital 'Tor Vergata', Rome, Italy., Di Perri G; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy., Antinori A; Clinical Division of HIV/AIDS, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Mussini C; Clinic of Infectious Diseases, University Hospital, University of Modena and Reggio Emilia, Modena, Italy., Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Monforte AD; Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy., Perno CF; Virology Unit, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Santoro MM; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Publikováno v:
Antiviral therapy [Antivir Ther] 2019; Vol. 24 (5), pp. 321-331.
Autor:
Santoro MM; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy., Di Carlo D; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy., Armenia D; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy., Zaccarelli M; Infectious Diseases Division, National Institute for Infectious Diseases L Spallanzani (IRCCS), Rome, Italy., Pinnetti C; Infectious Diseases Division, National Institute for Infectious Diseases L Spallanzani (IRCCS), Rome, Italy., Colafigli M; Clinic of Dermatology and Infectious Diseases, San Gallicano Dermatologic Institute (IRCCS), Rome, Italy., Prati F; Infectious Diseases Unit, Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Italy., Boschi A; Infectious Diseases Unit, Azienda Ospedaliera di Rimini, Rimini, Italy., Antoni AMD; Infectious Diseases Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy., Lagi F; Department of Tropical and Infectious Diseases, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Sighinolfi L; Infectious Diseases Unit, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy., Gervasoni C; Section of Infectious Diseases, L Sacco University Hospital, Milan, Italy., Andreoni M; Department of Medicine of Systems, University of Rome 'Tor Vergata', Rome, Italy., Antinori A; Infectious Diseases Division, National Institute for Infectious Diseases L Spallanzani (IRCCS), Rome, Italy., Mussini C; Clinic of Infectious Diseases, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy., Perno CF; Antiretroviral Drugs Monitoring Unit, National Institute for Infectious Diseases L Spallanzani (IRCCS), Rome, Italy., Borghi V; Clinic of Infectious Diseases, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy., Sterrantino G; Department of Tropical and Infectious Diseases, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Publikováno v:
Antiviral therapy [Antivir Ther] 2018; Vol. 23 (3), pp. 249-257.
Autor:
Falasca F; Department of Molecular Medicine, 'Sapienza' University of Rome, Viale dell'Università 31, 00185, Rome, Italy., Di Carlo D; Department of Molecular Medicine, 'Sapienza' University of Rome, Viale dell'Università 31, 00185, Rome, Italy., De Vito C; Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy., Bon I; Microbiology Section of the Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, University of Bologna, Bologna, Italy., d'Ettorre G; Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy., Fantauzzi A; Department of Clinical Medicine, 'Sapienza' University of Rome, Rome, Italy., Mezzaroma I; Department of Clinical Medicine, 'Sapienza' University of Rome, Rome, Italy., Fimiani C; Umberto I University Hospital, Rome, Italy., Re MC; Microbiology Section of the Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, University of Bologna, Bologna, Italy., Vullo V; Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy., Antonelli G; Department of Molecular Medicine, 'Sapienza' University of Rome, Viale dell'Università 31, 00185, Rome, Italy., Turriziani O; Department of Molecular Medicine, 'Sapienza' University of Rome, Viale dell'Università 31, 00185, Rome, Italy. ombretta.turriziani@uniroma1.it.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2017 Aug 22; Vol. 17 (1), pp. 581. Date of Electronic Publication: 2017 Aug 22.
Autor:
Antonucci F; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Cento V; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Sorbo MC; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Manuelli MC; Liver Unit, Polyclinic Tor Vergata Foundation, University of Rome Tor Vergata, Rome, Italy., Lenci I; Hepatology Unit, Polyclinic Tor Vergata Foundation, University of Rome Tor Vergata, Rome, Italy., Sforza D; Liver Unit, Polyclinic Tor Vergata Foundation, University of Rome Tor Vergata, Rome, Italy., Di Carlo D; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Milana M; Hepatology Unit, Polyclinic Tor Vergata Foundation, University of Rome Tor Vergata, Rome, Italy., Manzia TM; Liver Unit, Polyclinic Tor Vergata Foundation, University of Rome Tor Vergata, Rome, Italy., Angelico M; Hepatology Unit, Polyclinic Tor Vergata Foundation, University of Rome Tor Vergata, Rome, Italy., Tisone G; Liver Unit, Polyclinic Tor Vergata Foundation, University of Rome Tor Vergata, Rome, Italy., Perno CF; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Ceccherini-Silberstein F; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. Electronic address: ceccherini@med.uniroma2.it.
Publikováno v:
Journal of virological methods [J Virol Methods] 2017 Aug; Vol. 246, pp. 1-7. Date of Electronic Publication: 2017 Apr 11.
Autor:
Armenia D; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Di Carlo D; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Calcagno A; Division of Infectious Diseases, University of Turin, Turin, Italy., Vendemiati G; Division of Infectious Diseases, University of Turin, Turin, Italy., Forbici F; Antiretroviral Drug Monitoring Laboratory, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Bertoli A; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Berno G; Antiretroviral Drug Monitoring Laboratory, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Carta S; Antiretroviral Drug Monitoring Laboratory, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Continenza F; Antiretroviral Drug Monitoring Laboratory, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Fedele V; Antiretroviral Drug Monitoring Laboratory, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Bellagamba R; Infectious Diseases Division, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Cicalini S; Infectious Diseases Division, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Ammassari A; Infectious Diseases Division, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Libertone R; Infectious Diseases Division, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Zaccarelli M; Infectious Diseases Division, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Ghisetti V; Division of Infectious Diseases, University of Turin, Turin, Italy., Andreoni M; Systems Medicine, University of Rome Tor Vergata, Rome, Italy., Ceccherini-Silberstein F; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Bonora S; Division of Infectious Diseases, University of Turin, Turin, Italy., Di Perri G; Division of Infectious Diseases, University of Turin, Turin, Italy., Antinori A; Infectious Diseases Division, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Perno CF; Antiretroviral Drug Monitoring Laboratory, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy., Santoro MM; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2017 Mar 01; Vol. 72 (3), pp. 855-865.
Autor:
Armenia D; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Di Carlo D; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Maffongelli G; Infectious Diseases Division, University Hospital Tor Vergata, Rome, Italy., Borghi V; Infectious Diseases Division, Modena University Hospital, Modena, Italy., Alteri C; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Forbici F; Antiretroviral Therapy Monitoring Unit, L Spallanzani Hospital, Rome, Italy., Bertoli A; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.; Molecular Virology Division, University Hospital Tor Vergata, Rome, Italy., Gori C; Antiretroviral Therapy Monitoring Unit, L Spallanzani Hospital, Rome, Italy., Giuliani M; Infectious Dermatology Unit, San Gallicano Hospital, Rome, Italy., Nicastri E; Infectious Diseases Division, L Spallanzani Hospital, Rome, Italy., Zaccarelli M; Infectious Diseases Division, L Spallanzani Hospital, Rome, Italy., Pinnetti C; Infectious Diseases Division, L Spallanzani Hospital, Rome, Italy., Cicalini S; Infectious Diseases Division, L Spallanzani Hospital, Rome, Italy., D'Offizi G; Infectious Diseases Division, L Spallanzani Hospital, Rome, Italy., Ceccherini-Silberstein F; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy., Mussini C; Infectious Diseases Division, Modena University Hospital, Modena, Italy., Antinori A; Infectious Diseases Division, L Spallanzani Hospital, Rome, Italy., Andreoni M; Infectious Diseases Division, University Hospital Tor Vergata, Rome, Italy., Perno CF; Antiretroviral Therapy Monitoring Unit, L Spallanzani Hospital, Rome, Italy., Santoro MM; Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Publikováno v:
HIV medicine [HIV Med] 2017 Jan; Vol. 18 (1), pp. 21-32. Date of Electronic Publication: 2016 Jun 28.
Autor:
Santoro MM; University of Rome Tor Vergata., Fabeni L, Armenia D, Alteri C, Di Pinto D, Forbici F, Bertoli A, Di Carlo D, Gori C, Carta S, Fedele V, D'Arrigo R, Berno G, Ammassari A, Pinnetti C, Nicastri E, Latini A, Tommasi C, Boumis E, Petrosillo N, D'Offizi G, Andreoni M, Ceccherini-Silberstein F, Antinori A, Perno CF
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2014 Apr; Vol. 58 (8), pp. 1156-64. Date of Electronic Publication: 2014 Jan 14.
Autor:
Marco Bongiovanni, D. Di Carlo, Alessandro Marra, Francesco Bini, Mario Schettino, Bruno Dino Bodini, Desiree Picascia, A. De Lauretis, A. Bellini, L. Pellegrini, Giampiero Manes
Publikováno v:
The Journal of Hospital Infection
Journal of Hospital Infection
Journal of Hospital Infection
At present, the time-frame used for the quarantine of individuals with coronavirus disease 2019 (COVID-19) is the entire duration of symptoms plus 14 days after symptom recovery; however, no data have been reported specifically for healthcare workers